Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2023-11-21 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed tables of repurchase transactions with dates and share quantities. The document references compliance with listing rules of the Hong Kong Stock Exchange and confirms authorization by the board of directors. There is no indication of financial statements, earnings data, or management discussion. The content focuses on share repurchase activities and changes in issued shares, which aligns with reporting on transactions in own shares. The document is lengthy (15,000 characters) and contains substantive data, not merely an announcement or certification. Therefore, the appropriate classification is a report on share repurchase activities, fitting the category 'Transaction in Own Shares' (POS).
2023-11-21 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase transactions and changes in share capital, not on financial results, management commentary, or other report types. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-11-20 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules and legal requirements. The content focuses on share repurchase activities and changes in share capital, consistent with disclosures required by stock exchange rules. There is no indication of it being a full financial report, earnings release, or management discussion. It is a regulatory disclosure about share capital changes and repurchases, fitting the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transactional data, not merely an announcement or certification, supporting this classification with high confidence.
2023-11-17 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase transactions and changes in issued shares, not on financial results, management changes, or other report types. This matches the description of a Transaction in Own Shares filing, which reports company buybacks or sales of its own shares. The document is substantive and detailed, not a brief announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-11-16 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is a regulatory disclosure about share capital changes and repurchases, not a financial report or earnings release. It is a formal notification of share transactions by the company, specifically about repurchases of its own shares. This fits the category of 'Transaction in Own Shares' (POS) filings, which report share buybacks or sales by the company. The document is lengthy and detailed, not a brief announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is POS with high confidence.
2023-11-15 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed data on repurchases of shares over multiple dates, including quantities and percentages. The document references compliance with listing rules of the Hong Kong Stock Exchange and includes confirmations about authorization and legal compliance related to share issues and repurchases. There is no indication of financial statements, earnings data, management discussion, or other report types. The content is focused on reporting share repurchase transactions, which aligns with the category for company transactions involving its own shares. Therefore, the document is best classified as a 'Transaction in Own Shares' filing.
2023-11-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.